President Trump speaks at the White House, April 29, 2020 (Mandel Ngan/AFP via Getty Images)

Covid-19 roundup: GSK CEO Em­ma Walm­s­ley — some tri­al de­lays, but we’re lim­it­ing the dam­age — so far; Trump plan­ning ‘Warp Speed’ vac­cine plan

All the ma­jor phar­mas are wrestling with the Covid-19 out­break in one way or an­oth­er. For some, like Eli Lil­ly, the ex­ec­u­tive teams have de­layed pa­tient re­cruit­ment on a wide num­ber of tri­als, which will like­ly have a deep im­pact on de­vel­op­ment plans — par­tic­u­lar­ly at the ear­li­er stages.

But over at Glax­o­SmithK­line, the em­pha­sis has been on find­ing ways to keep its op­er­a­tions on track — in­clud­ing R&D. Here’s a lengthy set of re­marks from Em­ma Walm­s­ley’s Q1 re­view, which help en­cap­su­late both the ef­fects of the out­break and their strat­e­gy for deal­ing with it.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.